These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 31659725)

  • 1. Cystic Fibrosis: Pathophysiology of Lung Disease.
    Bergeron C; Cantin AM
    Semin Respir Crit Care Med; 2019 Dec; 40(6):715-726. PubMed ID: 31659725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CFTR in airway disease.
    Pilewski JM; Frizzell RA
    Physiol Rev; 1999 Jan; 79(1 Suppl):S215-55. PubMed ID: 9922383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology.
    Clunes MT; Boucher RC
    Methods Mol Biol; 2011; 742():3-14. PubMed ID: 21547723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets.
    Haq IJ; Gray MA; Garnett JP; Ward C; Brodlie M
    Thorax; 2016 Mar; 71(3):284-7. PubMed ID: 26719229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion channels as targets to treat cystic fibrosis lung disease.
    Martin SL; Saint-Criq V; Hwang TC; Csanády L
    J Cyst Fibros; 2018 Mar; 17(2S):S22-S27. PubMed ID: 29102290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloride Conductance, Nasal Potential Difference and Cystic Fibrosis Pathophysiology.
    Procianoy EDFA; de Abreu E Silva FA; Maróstica PJC; Quinton PM
    Lung; 2020 Feb; 198(1):151-156. PubMed ID: 31734731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.
    Jiang Q; Engelhardt JF
    Eur J Hum Genet; 1998 Jan; 6(1):12-31. PubMed ID: 9781011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of Ion Transport to Restore Airway Hydration in Cystic Fibrosis.
    Reihill JA; Douglas LEJ; Martin SL
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33810137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics.
    Kunzelmann K; Mall M
    Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
    Kuk K; Taylor-Cousar JL
    Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unified Airway-Cystic Fibrosis.
    Cho DY; Grayson JW; Woodworth BA
    Otolaryngol Clin North Am; 2023 Feb; 56(1):125-136. PubMed ID: 36266104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in understanding mucus abnormalities in cystic fibrosis airways.
    Wine JJ; Hansson GC; König P; Joo NS; Ermund A; Pieper M
    J Cyst Fibros; 2018 Mar; 17(2S):S35-S39. PubMed ID: 28951068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What's new in cystic fibrosis? From treating symptoms to correction of the basic defect.
    Proesmans M; Vermeulen F; De Boeck K
    Eur J Pediatr; 2008 Aug; 167(8):839-49. PubMed ID: 18389279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis.
    Shei RJ; Peabody JE; Kaza N; Rowe SM
    Curr Opin Pharmacol; 2018 Dec; 43():152-165. PubMed ID: 30340955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease.
    Moore PJ; Tarran R
    Expert Opin Ther Targets; 2018 Aug; 22(8):687-701. PubMed ID: 30028216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease.
    Verkman AS; Song Y; Thiagarajah JR
    Am J Physiol Cell Physiol; 2003 Jan; 284(1):C2-15. PubMed ID: 12475759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperacidification in cystic fibrosis: links with lung disease and new prospects for treatment.
    Poschet J; Perkett E; Deretic V
    Trends Mol Med; 2002 Nov; 8(11):512-9. PubMed ID: 12421684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopathology of Airway Surface Liquid Dehydration Disease.
    Lewis BW; Patial S; Saini Y
    J Immunol Res; 2019; 2019():2180409. PubMed ID: 31396541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiopathology of cystic fibrosis lung disease].
    Chinet T
    Rev Mal Respir; 1999 Jun; 16(3):339-45. PubMed ID: 10472642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.